News from cellular biomedicine group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 13, 2020, 07:29 ET Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical Programs

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...


Jun 29, 2020, 08:55 ET Cellular Biomedicine Group (CBMG) Announces Results of 2020 Annual Meeting of Stockholders

Cellular Biomedicine Group Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Jun 22, 2020, 09:00 ET Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual Meeting

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


May 26, 2020, 08:00 ET Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


May 06, 2020, 16:16 ET Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


May 01, 2020, 16:15 ET Cellular Biomedicine Group to Report First Quarter 2020 Results on May 6, 2020

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Feb 28, 2020, 16:05 ET Cellular Biomedicine Group Announces Q4 and Full Year 2019 Financial Results and Recent Operational Progress

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...


Dec 30, 2019, 08:30 ET Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG") today announced that the special committee of its board of directors, composed of Alan Au,...


Dec 07, 2019, 08:00 ET Cellular Biomedicine Group Presents First Clinical Data of IIT Phase 1 Trial of C-CAR088, a Novel BCMA CAR-T, at the 61st Annual Meeting of the American Society of Hematology

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Nov 11, 2019, 10:00 ET Cellular Biomedicine Group Announces Receipt of a Preliminary Non-Binding "Going Private" Proposal

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Nov 06, 2019, 16:36 ET Cellular Biomedicine Group Reports Third Quarter of 2019 Financial Results and Business Highlights

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Oct 30, 2019, 08:00 ET Cellular Biomedicine Group to Report Third Quarter 2019 Results on November 6, 2019

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Oct 02, 2019, 08:37 ET Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...


Oct 01, 2019, 16:30 ET Cellular Biomedicine Group to Present at the 2019 Cantor Global Healthcare Conference

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Sep 27, 2019, 22:49 ET Cellular Biomedicine Group's ReJoin® Therapy Receives Stem Cell Drug Application Acceptance For Phase II Clinical Trials by China NMPA

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the development of immunotherapies for ...


Sep 12, 2019, 07:30 ET Cellular Biomedicine Group Hosts Meeting with Investigators to Launch AlloJoin® Knee Osteoarthritis Phase II Clinical Trial

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Sep 09, 2019, 09:28 ET Cellular Biomedicine Group to Present at 5th Annual CAR-TCR Summit in Boston

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Aug 29, 2019, 08:31 ET Cellular Biomedicine Group to Present at Baird's 2019 Global Healthcare Conference

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Aug 06, 2019, 16:10 ET Cellular Biomedicine Group Reports Second Quarter and First Half of 2019 Financial Results and Business Highlights

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Jul 23, 2019, 08:40 ET Cellular Biomedicine Group to Report Second Quarter 2019 Results on August 6, 2019

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Jun 18, 2019, 07:30 ET ­Cellular Biomedicine Group Executives to Present at CAR-TCR Summit Asia

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Jun 17, 2019, 07:00 ET Cellular Biomedicine Group Announces First Patient Dosing in Phase I Clinical Trial of Anti-CD20 CAR-T for Lymphoma in China

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


May 29, 2019, 08:45 ET Cellular Biomedicine Group to Present at International Society for Cell and Gene Therapy Annual Meeting

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


May 20, 2019, 08:00 ET Cellular Biomedicine Group to Present at B. Riley FBR Annual Investor Conference

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Apr 30, 2019, 17:24 ET Cellular Biomedicine Group Reports First Quarter 2019 Results and Highlights Operational Progress

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...